科研成果奖 (1)潘薛波(2/9),基于恶性肿瘤FGF信号分子靶标筛选新型拮抗肽的基础与应用研究,浙江省科学技术厅,浙江省科学技术进步奖,二等奖, 2017。 (2)潘薛波(2/6), FGF21在动脉粥样硬化发病中的作用机制研究,浙江省卫生计生委,浙江省医药卫生科技奖,二等奖, 2017。 授权专利 (1)潘薛波、赵凯、朱诚、王飞娟、高建青、陈文莉,番红花球茎愈伤组织的诱导与抗肿瘤有效活性成份的提取方法,2010.1.6,中国,ZL 200710067537.X。 (2)王飞娟、潘薛波、赵凯、朱诚、高建青、陈文莉,红托竹荪菌托中具有抑制肿瘤细胞生长的多糖的分离方法。2009.8.19,中国,ZL 200710067536.5。 (3)王飞娟,朱诚、潘薛波、赵凯、高建青、陈文莉,番红花球茎中具有抗肿瘤效果的有效活性成份的提取方法。2010.9.8,中国,ZL 200710067535.0。 |
3.发表论文(具有代表性的5篇)
(1)Fan Z#, Ma J#,Pan X#, Zhao L, Wu Y, Lin H, Zhao Y, Jiang H, Pan T, Li X*, Wang F*, Wang C*. Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells. Int J Cancer. 2022 May 1;150(9):1525-1536.(并列第一作者,IF:7.316) (2)Li S#, Zhu Z#, Xue M#, Pan X#, Tong G, Yi X, Fan J, Li Y, Li W, Dong Y, Shen E, Gong W, Wang X, Yu Y, Maeng YJ, Li X, Lee KY*, Jin L*, Cong W*. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biol. 2021 Apr;40:101859.(并列第一作者,IF:10.787) (3)Wang C#, Li Y#, Li H#, Zhang Y, Ying Z, Wang X, Zhang T, Zhang W, Fan Z, Li X*, Ma J*, Pan X*. Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells. Front Cell Dev Biol. 2020 Jul 22;8:601.(最后通讯作者,IF:6.081) (4)Yingying Pan#, Baile Wang#, Jujia Zheng, Rongrong Xiong, Zhichao Fan, Yanna Ye, Saiai Zhang, Qinyao Li, FanghuaGong, Chaoming Wu, Zhuofeng Lin, Xiaokun Li*, Xuebo Pan*, Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling-dependent manner. J Cell Mol Med, 2019, 23(2): 1059-1071.(最后通讯作者,IF:5.295) (5) Xuebo Pan#, Yihui Shao#, Fan Wu#, Yuan Wang#, Rongrong Xiong, Jujia Zheng, Haishan Tian, Baile Wang, Yanfang Wang, Yi Zhang, Zongsheng Han , Aijuan Qu, Haixia Xu, Aihua Lu, Tianxin Yang, Xiaokun Li, Aimin Xu, Jie Du, Zhuofeng Lin*, FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1-7) Axis in Mice. Cell Metab, 2018, 27(6): 1323-1337.(第一作者,IF:31.373) |